ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
9 |
28/05/22 |
28/05/22 |
ASX - By Stock
|
287
|
58K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Dr Neal Shore joins Clarity's CAB
|
|
ejjwj
|
3 |
1.0K |
2 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
3
|
1.0K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex to Present at Aerospace Medical Association Meeting
|
|
ejjwj
|
4 |
1.3K |
7 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
4
|
1.3K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
5 |
05/05/22 |
05/05/22 |
ASX - By Stock
|
142
|
38K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
3 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
142
|
38K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
ClinicalTrials.gov - IHH EVOLVE - We are in the system !
|
|
ejjwj
|
28 |
6.8K |
1 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
28
|
6.8K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
ClinicalTrials.gov - IHH EVOLVE - We are in the system !
|
|
ejjwj
|
28 |
6.8K |
3 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
28
|
6.8K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
2 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
142
|
38K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
3 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
287
|
58K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
7 |
18/04/22 |
18/04/22 |
ASX - By Stock
|
287
|
58K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
ejjwj
|
234 |
85K |
4 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
234
|
85K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
ejjwj
|
234 |
85K |
1 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
234
|
85K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
3 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
142
|
38K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
4 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
142
|
38K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
4 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
142
|
38K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex to Present at Upcoming Tech Biotech Broker Briefing
|
|
ejjwj
|
26 |
5.1K |
3 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
26
|
5.1K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
3 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
142
|
38K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
5 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
142
|
38K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
The PRIMARY Score: PSMA PET/CT prostate cancer diagnosis.
|
|
ejjwj
|
9 |
3.9K |
2 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
9
|
3.9K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
AANMS announces PSMA/PET availble through MBS from July1
|
|
ejjwj
|
10 |
4.1K |
2 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
10
|
4.1K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
AANMS announces PSMA/PET availble through MBS from July1
|
|
ejjwj
|
10 |
4.1K |
3 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
10
|
4.1K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
4 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
287
|
58K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
ejjwj
|
234 |
85K |
5 |
03/04/22 |
03/04/22 |
ASX - By Stock
|
234
|
85K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
3 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
142
|
38K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
2 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
142
|
38K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
$3.38 Valuation | $0.60c Current SP | Fully Funded Phase 3 with First Patient in Coming Months
|
|
ejjwj
|
142 |
38K |
4 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
142
|
38K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Development of Glioblastoma Therapy Program
|
|
ejjwj
|
14 |
5.2K |
4 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
14
|
5.2K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex to Present at Upcoming Tech Biotech Broker Briefing
|
|
ejjwj
|
26 |
5.1K |
2 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
26
|
5.1K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
4 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
287
|
58K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: 1st Patient Dosed ProstACT Prostate Cancer Therapy Program
|
|
ejjwj
|
4 |
2.3K |
12 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
4
|
2.3K
|
12
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
1 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
287
|
58K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
7 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
287
|
58K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
2 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
287
|
58K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
0 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
287
|
58K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notice of Investor Call and Appendix 4C
|
|
ejjwj
|
11 |
1.5K |
2 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
11
|
1.5K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
5 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
287
|
58K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Trading Halt
|
|
ejjwj
|
36 |
15K |
12 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
36
|
15K
|
12
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Trading Halt
|
|
ejjwj
|
36 |
15K |
6 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
36
|
15K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
The path to a Billion Dollar + company
|
|
ejjwj
|
287 |
58K |
1 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
287
|
58K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021
|
|
ejjwj
|
168 |
25K |
1 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
168
|
25K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021
|
|
ejjwj
|
168 |
25K |
1 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
168
|
25K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notice of Webinar & Investor Presentation
|
|
ejjwj
|
32 |
4.5K |
8 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
32
|
4.5K
|
8
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notice of Webinar & Investor Presentation
|
|
ejjwj
|
32 |
4.5K |
5 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
32
|
4.5K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021
|
|
ejjwj
|
168 |
25K |
1 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
168
|
25K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
ejjwj
|
172 |
18K |
1 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
172
|
18K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Approval
|
|
ejjwj
|
48 |
18K |
2 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
48
|
18K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
ejjwj
|
172 |
18K |
0 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
172
|
18K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
ejjwj
|
172 |
18K |
3 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
172
|
18K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
16 |
3.5K |
4 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
16
|
3.5K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Invex in Space?
|
|
ejjwj
|
37 |
7.0K |
0 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
37
|
7.0K
|
0
|
|